ADARx Pharmaceuticals is based in San Diego. It has raised $200M in total funding. Latest round: Series C.
ADARx Pharmaceuticals is based in San Diego. ADARx Pharmaceuticals has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2023. The round record for ADARx Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, TCGX, Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare Investments and 10 others. 16 distinct backers are named across the disclosed rounds.
Round data for ADARx Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026